Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study
This cohort/real-world study was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
This cohort/real-world study was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
What the study was
- Study design
- Cohort/real-world study
- Sample size
- 925
- Maturity
- Validated
- Journal
- Journal of hematology & oncology
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.